.Pharmacolibrary.Drugs.V_Various.V08D_UltrasoundContrastMedia.V08DA05_SulfurHexafluoridePhosph.SulfurHexafluoridePhosph

Information

name:SulfurHexafluoridePhospholipidMicrospheres
ATC code:V08DA05
route:intravenous
n-compartments2

Sulfur hexafluoride, phospholipid microspheres (marketed as SonoVue or Lumason) is an ultrasound contrast agent approved for use in echocardiography and selected radiology procedures. It is a suspension of sulfur hexafluoride gas encapsulated by phospholipid microspheres, used diagnostically to enhance the ultrasound imaging of blood vessels, cardiac chambers, and specific organs. The agent is currently approved and in clinical use in various regions.

Pharmacokinetics

Pharmacokinetic parameters reported in healthy adult volunteers after intravenous bolus administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos